glp 1 is insulin Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine Schematic pathway showing release of
Description
DOI: 10.1038/nature02006 [Google Scholar] Kuo CY, Tsou SH, Kornelius E, Chan KC, Chang KW, Li JC, et al

Additionally, Tirzepatide has been proven to lower the risk of major cardiovascular events in individuals with type 2 diabetes and other related health conditions

& Consoli, A

Those taking the drug showed significantly less shrinkage in key brain regions, including their temporal lobe and overall grey matter

To maintain results, patients must stay on GLP-1s indefinitely
